December 11, 2015
Biophytis Appoints of Roger A. Fielding, Ph.D., as a Scientific Consultant for Company’s SARCOB Clinical Development Program. Download the Press Release
Biophytis Appoints of Roger A. Fielding, Ph.D., as a Scientific Consultant for Company’s SARCOB Clinical Development Program. Download the Press Release
Biophytis Appoints Pierre J. Dilda as Director of Research. Read the Press Release
Biophytis to present preclinical proof of concept for Sarcob to treat sarcopenic obesity at SCWD on December 4th. Download the Press Release
Biophytis establishes Boston subsidiary to accelerate clinical development. Download the Press Release
BIOPHYTIS Invited to Attend the Jefferies 2015 Global Healthcare Conference. Read the press release
BIOPHYTIS initiates the clinical batches production of BIO101, the first step in the ongoing phase 2b trial in the sarcopenic obesity. Click here to download the Press Release
BIOPHYTIS completes an international private placement of 6M€ to conduct its development strategy. Click here to download the Press Release
BIOPHYTIS strengthens its senior management team. Click here to download the Press Release